VanEck Associates’s Synaptics SYNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Buy
21,942
+5,993
+38% +$677K ﹤0.01% 975
2026
Q1
$1.12M Sell
15,949
-5,456
-25% -$443K ﹤0.01% 1071
2025
Q4
$1.58M Buy
21,405
+3,265
+18% +$229K ﹤0.01% 1025
2025
Q3
$1.24M Buy
18,140
+9,234
+104% +$628K ﹤0.01% 1053
2025
Q2
$577K Buy
8,906
+475
+6% +$27.9K ﹤0.01% 1144
2025
Q1
$537K Buy
8,431
+2,677
+47% +$194K ﹤0.01% 1142
2024
Q4
$439K Buy
5,754
+3,906
+211% +$296K ﹤0.01% 1154
2024
Q3
$132K Buy
+1,848
New +$148K ﹤0.01% 1231

Other funds holding SYNA

VanEck Associates's SYNA Position: Q2 2026 in Review

VanEck Associates increased its Synaptics (SYNA) stake by 38% in Q2 2026, buying an estimated $677K and bringing the position to 21,942 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #975.

VanEck Associates first reported a position in SYNA in Q3 2024 and has held it in 8 quarters since. 374 funds tracked by Wall St. Rank hold SYNA as of Q2 2026.

  • VanEck Associates held 21,942 shares of Synaptics worth $2.73M as of Q2 2026.
  • VanEck Associates bought 5,993 Synaptics shares in Q2 2026, an estimated $677K.
  • Synaptics made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #975 holding.
  • VanEck Associates first reported a position in Synaptics in Q3 2024 and has held it in 8 quarters since.
  • 374 funds tracked by Wall St. Rank held Synaptics as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.